
Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

Johnson & Johnson has chosen the UK as its formal European hub after announcing the creation of five new sites …

GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
A new study has shown that public confidence in health research studies can be increased by knowing that patients have …

Small medical research charities are worried that the extra costs of open access publishing will have a significant impact on …

There is new hope that Alzheimer’s disease could be cured, according to a discovery by scientists from the Medical Research …

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …

Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …

A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers …
London 2012 could provide a boost in the continuing search for personalised medicines for diabetes, heart disease and dementia as …

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …

AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …
There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …
The British Pharmacology Society (BPS) is the primary UK learned society concerned with research into drugs and the way they …